CEO SUMMARY: The proposed 2027 OPPS rule would move certain algorithm-driven analyses off the Clinical Laboratory Fee Schedule, potentially creating a new reimbursement framework for AI-enabled diagnostics. For clinical laboratories, it could shift how reimbursement weaves into software-driven insight of diagnostic tests. Clinical laboratory leaders who are looking now for clues about future diagnostic test […]
To access this post, you must purchase The Dark Report.